(Q37662517)

21 August 2017

1 reference

title

Bosentan: in pediatric patients with pulmonary arterial hypertension (English)

1 reference

21 August 2017

main subject

arterial hypertension

0 references

2

Gillian M Keating

1 reference

21 August 2017

Natalie J Carter

1

1 reference

21 August 2017

publication date

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

12

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

63-73

1 reference

https://scigraph.springernature.com/pub.10.2165/11203970-000000000-00000

21 August 2017

exact match

0 references

cites work

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11203970-000000000-00000

Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program

21 January 2018

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

12 December 2020

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis

1 reference

12 December 2020

Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers

1 reference

12 December 2020

Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis

1 reference

12 December 2020

Effects of long-term bosentan in children with pulmonary arterial hypertension.

1 reference

12 December 2020

Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs

1 reference

12 December 2020

Biological serum markers in the management of pediatric pulmonary arterial hypertension

1 reference

12 December 2020

Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006.

1 reference

12 December 2020

The management of pulmonary hypertension in children

1 reference

12 December 2020

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

1 reference

12 December 2020

Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?

1 reference

12 December 2020

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist

1 reference

12 December 2020

1 reference

12 December 2020

Effect of bosentan on plasma endothelin-1 concentration in patients with pulmonary arterial hypertension

1 reference

12 December 2020

Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis

1 reference

12 December 2020

Response to bosentan in children with pulmonary hypertension

1 reference

12 December 2020

Clinical pharmacology of bosentan, a dual endothelin receptor antagonist

1 reference

12 December 2020

Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.

1 reference

12 December 2020

The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension

1 reference

12 December 2020

Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study

1 reference

12 December 2020

Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension

1 reference

12 December 2020

Pulmonary arterial hypertension in children

1 reference

12 December 2020

Endothelin receptor antagonists for pulmonary arterial hypertension: rationale and place in therapy

1 reference

12 December 2020

Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment

1 reference

12 December 2020

Absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects

1 reference

12 December 2020

10.2165/11203970-000000000-00000

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rpty7vhzbza7dkqbu5tcf5gwmm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_rpty7vhzbza7dkqbu5tcf5gwmm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rpty7vhzbza7dkqbu5tcf5gwmm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/rpty7vhzbza7dkqbu5tcf5gwmm

1 reference

30 July 2022